logo
episode-header-image
Aug 2023
9m 10s

The weight-loss drug craze

Financial Times
About this episode

The UK government is pushing back against an attempt by some members of the House of Lords to close loopholes in transparency legislation, US bank stocks fell after Moody’s cut the credit ratings of 10 midsized banks, and the FT’s Jamie Smyth explains the craze behind new weight-loss drugs. 


Mentioned in this podcast:

UK government resists moves to tighten corporate transparency rules

Weak bank stocks weigh on US and European markets 

Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks

Orange juice futures hit record high after storms ravage Florida crop


The FT News Briefing is produced by Fiona Symon, Sonja Hutson and Marc Filippino. Additional help from Monica Lopez, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music.


Read a transcript of this episode on FT.com


Hosted on Acast. See acast.com/privacy for more information.

Up next
Today
What an AI slowdown could mean for investors
Tech stocks fell yesterday as markets reacted to ongoing talk of an AI apocalypse, industrial America is contending with a fresh wave of supply chain inflation, and foreign investors are now buying more US stocks than government bonds. Plus, China has implemented sweeping new con ... Show More
11m 45s
Yesterday
Fed and BoJ expect rate hikes as US bond market flails
US Treasury secretary Scott Bessent’s interventions in the American bond market haven’t worked so far, but could interest rate decisions from the Federal Reserve and Bank of Japan this week change things? Plus, Russia hit a Ukrainian train line moments after foreign dignitaries t ... Show More
11m 37s
Sep 11
Oil hits $108 ahead of Iran’s meeting with Gulf states
US long-term borrowing costs surged to their highest level in more than two decades, and Gulf foreign ministers plan to meet their Iranian counterpart to negotiate a deal temporarily managing shipping through the Strait of Hormuz. Plus, Brics – the developing world’s answer to th ... Show More
11m 1s
Recommended Episodes
Feb 2024
The obesity drug craze is entering its next phase
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ... Show More
22m 46s
Apr 2023
Those New Obesity Drugs Really Work–If You Can Afford Them
Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ... Show More
25m 18s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
Oct 2024
Hot shot: the wider promise of weight-loss jabs
<p>First they treated diabetes. Then obesity. Now <a href="https://www.economist.com/leaders/2024/10/24/its-not-just-obesity-drugs-like-ozempic-will-change-the-world?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.t ... Show More
23m 58s